NRC Health Statistics
Total Valuation
NRC Health has a market cap or net worth of $444.16 million. The enterprise value is $531.28 million.
| Market Cap | 444.16M |
| Enterprise Value | 531.28M |
Important Dates
The next confirmed earnings date is Tuesday, October 27, 2026, after market close.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Sep 25, 2026 |
Share Statistics
NRC Health has 22.12 million shares outstanding. The number of shares has decreased by -5.38% in one year.
| Current Share Class | 22.12M |
| Shares Outstanding | 22.12M |
| Shares Change (YoY) | -5.38% |
| Shares Change (QoQ) | +0.45% |
| Owned by Insiders (%) | 46.58% |
| Owned by Institutions (%) | 50.42% |
| Float | 11.82M |
Valuation Ratios
The trailing PE ratio is 83.53 and the forward PE ratio is 21.14.
| PE Ratio | 83.53 |
| Forward PE | 21.14 |
| PS Ratio | 3.17 |
| Forward PS | 3.01 |
| PB Ratio | 67.88 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 20.52 |
| P/OCF Ratio | 15.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.92, with an EV/FCF ratio of 24.55.
| EV / Earnings | 96.90 |
| EV / Sales | 3.79 |
| EV / EBITDA | 19.92 |
| EV / EBIT | 29.44 |
| EV / FCF | 24.55 |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 13.81.
| Current Ratio | 0.65 |
| Quick Ratio | 0.49 |
| Debt / Equity | 13.81 |
| Debt / EBITDA | 3.32 |
| Debt / FCF | 4.18 |
| Interest Coverage | 3.34 |
Financial Efficiency
Return on equity (ROE) is 42.03% and return on invested capital (ROIC) is 12.34%.
| Return on Equity (ROE) | 42.03% |
| Return on Assets (ROA) | 8.13% |
| Return on Invested Capital (ROIC) | 12.34% |
| Return on Capital Employed (ROCE) | 17.84% |
| Weighted Average Cost of Capital (WACC) | 5.45% |
| Revenue Per Employee | $392,148 |
| Profits Per Employee | $15,359 |
| Employee Count | 357 |
| Asset Turnover | 1.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRC Health has paid $3.53 million in taxes.
| Income Tax | 3.53M |
| Effective Tax Rate | 37.57% |
Stock Price Statistics
The stock price has increased by +64.46% in the last 52 weeks. The beta is 0.28, so NRC Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | +64.46% |
| 50-Day Moving Average | 20.97 |
| 200-Day Moving Average | 18.99 |
| Relative Strength Index (RSI) | 43.91 |
| Average Volume (20 Days) | 128,131 |
Short Selling Information
The latest short interest is 685,377, so 3.10% of the outstanding shares have been sold short.
| Short Interest | 685,377 |
| Short Previous Month | 636,681 |
| Short % of Shares Out | 3.10% |
| Short % of Float | 5.80% |
| Short Ratio (days to cover) | 5.79 |
Income Statement
In the last 12 months, NRC Health had revenue of $140.00 million and earned $5.48 million in profits. Earnings per share was $0.24.
| Revenue | 140.00M |
| Gross Profit | 86.45M |
| Operating Income | 18.05M |
| Pretax Income | 9.38M |
| Net Income | 5.48M |
| EBITDA | 26.68M |
| EBIT | 18.05M |
| Earnings Per Share (EPS) | $0.24 |
Balance Sheet
The company has $3.33 million in cash and $90.45 million in debt, with a net cash position of -$87.12 million or -$3.94 per share.
| Cash & Cash Equivalents | 3.33M |
| Total Debt | 90.45M |
| Net Cash | -87.12M |
| Net Cash Per Share | -$3.94 |
| Equity (Book Value) | 6.55M |
| Book Value Per Share | 0.30 |
| Working Capital | -12.21M |
Cash Flow
In the last 12 months, operating cash flow was $29.51 million and capital expenditures -$7.87 million, giving a free cash flow of $21.64 million.
| Operating Cash Flow | 29.51M |
| Capital Expenditures | -7.87M |
| Depreciation & Amortization | 8.63M |
| Net Borrowing | 8.95M |
| Free Cash Flow | 21.64M |
| FCF Per Share | $0.98 |
Margins
Gross margin is 61.75%, with operating and profit margins of 12.89% and 4.18%.
| Gross Margin | 61.75% |
| Operating Margin | 12.89% |
| Pretax Margin | 6.70% |
| Profit Margin | 4.18% |
| EBITDA Margin | 19.05% |
| EBIT Margin | 12.89% |
| FCF Margin | 15.46% |
Dividends & Yields
This stock pays an annual dividend of $0.64, which amounts to a dividend yield of 3.19%.
| Dividend Per Share | $0.64 |
| Dividend Yield | 3.19% |
| Dividend Growth (YoY) | 33.33% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 266.23% |
| FCF Payout Ratio | 65.42% |
| Buyback Yield | 5.38% |
| Shareholder Yield | 8.57% |
| Earnings Yield | 1.23% |
| FCF Yield | 4.87% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRC Health has an Altman Z-Score of 2.83 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.83 |
| Piotroski F-Score | 5 |